APTO

Aptose Biosciences Inc.

APTO | NASDAQ Capital Market

0.279USD0.1088 %

Break down Aptose Biosciences Inc.'s income statement to see revenues, costs, and profitability metrics.

Annual
Breakdown2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Total Revenue
0
0
0
0
0
0
0
0
Cost of Revenue
474.55 K
%-6.42
507.08 K
%-17.75
616.53 K
%-4.63
646.43 K
%3.06
627.25 K
%651.09
83.51 K
%-6.26
89.09 K
%-22.42
114.83 K
Gross Profit
-474.55 K
%-6.42
-507.08 K
%-17.75
-616.53 K
%-4.63
-646.43 K
%3.06
-627.25 K
%651.09
-83.51 K
%-6.26
-89.09 K
%-22.42
-114.83 K
Operating Expenses
52.36 M
%22.90
42.6 M
%-34.91
65.45 M
%17.36
55.77 M
%107.65
26.86 M
%-7.73
29.11 M
%146.13
11.83 M
%-14.84
13.89 M
Operating Income
-52.36 M
%22.92
-42.59 M
%-34.92
-65.45 M
%17.34
-55.78 M
%107.63
-26.86 M
%-7.71
-29.11 M
%146.13
-11.83 M
%-14.84
-13.89 M
Income Before Tax
-51.21 M
%22.44
-41.82 M
%-36.01
-65.35 M
%18.31
-55.24 M
%110.21
-26.28 M
%-8.98
-28.87 M
%147.56
-11.66 M
%-15.86
-13.86 M
Net Income
-51.21 M
%24.73
-41.05 M
%-37.09
-65.26 M
%19.29
-54.71 M
%112.90
-25.7 M
%-10.98
-28.87 M
%147.56
-11.66 M
%-15.86
-13.86 M
Basic EPS
-7.58
%13.64
-6.67
%-39.31
-10.99
%9.57
-10.03
%30.60
-7.68
%-40.79
-12.97
%65.43
-7.84
%-51.96
-16.32
EPS Diluted
-7.58
%13.64
-6.67
%-39.31
-10.99
%9.57
-10.03
%30.60
-7.68
%-40.79
-12.97
%65.43
-7.84
%-51.93
-16.31
Basic Average Shares
6.75 M
%9.82
6.15 M
%3.57
5.94 M
%8.86
5.46 M
%63.15
3.34 M
%50.22
2.23 M
%49.70
1.49 M
%75.15
849 K
Diluted Average Shares
6.75 M
%9.82
6.15 M
%3.57
5.94 M
%8.86
5.46 M
%63.15
3.34 M
%50.22
2.23 M
%49.65
1.49 M
%75.10
849.53 K
EBITDA
-52.27 M
%31.79
-39.66 M
%-38.19
-64.16 M
%11.57
-57.51 M
%119.00
-26.26 M
%-3.85
-27.31 M
%135.23
-11.61 M
%-15.71
-13.78 M